The cannabis world is abuzz with news about the latest federal Food & Drug Administration (FDA) report regarding cannabidiol (CBD). We break down what it is, and what it means for the industry and the regulatory landscape for...more
3/9/2020
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Corporate Counsel ,
Department of Health and Human Services (HHS) ,
E-Cigarettes ,
Enforcement Programs ,
Food and Drug Administration (FDA) ,
Information Reports ,
Regulatory Agencies ,
Regulatory Agenda
On October 31, 2019, the US Department of Agriculture (USDA) published a long-anticipated interim final rule on the production of hemp - defined as cannabis plant with a delta-9 tetrahydrocannabinol (THC) concentration of not...more
11/14/2019
/ Administrative Procedure ,
Cannabis Products ,
Clinical Laboratory Testing ,
Comment Period ,
Controlled Substances Act ,
Farm Bill ,
Hemp ,
Interim Final Rules (IFR) ,
Marijuana ,
Marijuana Related Businesses ,
Market Participants ,
Regulatory Agenda ,
Testing Requirements ,
Tribal Governments ,
USDA
After pressure from the US Senate, the FDA signals movement on CBD regulations.
The US Food and Drug Administration (FDA) Principal Deputy Commissioner Amy Abernathy, MD, PhD, recently announced via Twitter that the FDA...more